February 2016 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology”
A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.
Scientists discovered a new Tcelltreatmentthat could regrow hair. Users are skeptical but hopeful, with some relying on finasteride and minoxidil in the meantime.
Rosemary extract showed high inhibitory activity against DHT, similar to finasteride and dutasteride, butthe conversation includes skepticism about its effectiveness in humans since the study was done on mice and rosemary oil is often considered ineffective based on personal experiences. Some suggesttrying rosemary oil alongside other treatments, while others emphasize the difference between the extract used in the study and the oil.
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.
PP405 is in phase 2 trials for hair loss, with discussions on its cost and effectiveness compared to minoxidil and finasteride. Users are skeptical about its efficacy and timeline, with hopes for market release by 2027.